Want to see HK:2291 full AI Analyst Report?
Total Valuation
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H has a market cap or net worth of HK$4.07B. The enterprise value is HK$4.27K.
Market CapHK$4.07B
Enterprise ValueHK$4.27K
Share Statistics
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H has 346,750,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding346,750,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 11.75%.
Return on Equity (ROE)0.12
Return on Assets (ROA)0.11
Return on Invested Capital (ROIC)11.75%
Return on Capital Employed (ROCE)0.14
Revenue Per Employee1.43M
Profits Per Employee631.14K
Employee Count370
Asset Turnover0.25
Inventory Turnover0.73
Valuation Ratios
The current PE Ratio of LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H is 14.1. LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H’s PEG ratio is -7.43.
PE Ratio14.1
PS Ratio9.50
PB Ratio2.46
Price to Fair Value2.46
Price to FCF34.69
Price to Operating Cash Flow13.89
PEG Ratio-7.43
Income Statement
In the last 12 months, LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H had revenue of 527.94M and earned 239.73M in profits. Earnings per share was 0.69.
Revenue527.94M
Gross Profit446.95M
Operating Income276.54M
Pretax Income276.46M
Net Income239.73M
EBITDA292.60M
Earnings Per Share (EPS)0.69
Cash Flow
In the last 12 months, operating cash flow was 241.02M and capital expenditures -79.58M, giving a free cash flow of 161.44M billion.
Operating Cash Flow241.02M
Free Cash Flow161.44M
Free Cash Flow per Share0.47
Dividends & Yields
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H pays an annual dividend of HK$0.573, resulting in a dividend yield of 5.13%
Dividend Per ShareHK$0.573
Dividend Yield5.13%
Payout Ratio72.43%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.81
52-Week Price Change-53.80%
50-Day Moving Average10.65
200-Day Moving Average13.94
Relative Strength Index (RSI)51.61
Average Volume (3m)280.65K
Important Dates
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H upcoming earnings date is Aug 21, 2026, TBA (Confirmed).
Last Earnings DateMar 30, 2026
Next Earnings DateAug 21, 2026
Ex-Dividend Date―
Financial Position
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H as a current ratio of 23.54, with Debt / Equity ratio of 0.08%
Current Ratio23.54
Quick Ratio21.71
Debt to Market Cap<0.01
Net Debt to EBITDA-3.95
Interest Coverage Ratio2.37K
Taxes
In the past 12 months, LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H has paid 36.74M in taxes.
Income Tax36.74M
Effective Tax Rate0.13
Enterprise Valuation
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H EV to EBITDA ratio is 13.20, with an EV/FCF ratio of 26.70.
EV to Sales7.32
EV to EBITDA13.20
EV to Free Cash Flow26.70
EV to Operating Cash Flow17.47
Balance Sheet
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H has HK$1.16B in cash and marketable securities with HK$1.72M in debt, giving a net cash position of HK$1.16B billion.
Cash & Marketable SecuritiesHK$1.16B
Total DebtHK$1.72M
Net CashHK$1.16B
Net Cash Per ShareHK$3.33
Tangible Book Value Per ShareHK$4.55
Margins
Gross margin is 84.66%, with operating margin of 52.38%, and net profit margin of 45.41%.
Gross Margin84.66%
Operating Margin52.38%
Pretax Margin52.37%
Net Profit Margin45.41%
EBITDA Margin55.42%
EBIT Margin48.64%
Analyst Forecast
The average price target for LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast11.70%
EPS Growth Forecast-2.84%